[Alrheumum in the daily practice].
The new antirheumatic drug Ketoprofen (Alrheumun) has been tested by an open trial in 100 out-patients and the activity and tolerance have been evaluated under practice conditions. A daily dose of 3 capsules Alrheumun proved to have a good activity in patients with rheumatoid arthritis, osteoarthrosis and soft tissue conditions. 80% of all patients did not show to have any side-effects. Among all groups of patients, treatment had to be interupted because of side-effects in two patients only. A negative influence on any of the laboratory tests used was not found.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001577:Benzophenones / Q000627:therapeutic use*; D001786:Blood Glucose; D002062:Bursitis / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007660:Ketoprofen / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy; D052256:Tendinopathy / Q000188:drug therapy
D001577:Benzophenones; D001786:Blood Glucose; D007660:Ketoprofen
Alrheumun in der täglichen Praxis